Study of TAK-559 in Treating Subjects With Type 2 Diabetes Mellitus
Status:
Terminated
Trial end date:
2004-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study was to determine the safety of TAK-559, once daily (QD), in
treating subjects receiving a stable dose of insulin to control type 2 diabetes mellitus.